| Lobbyist Public Search |
|
Records prior to registration year 2005 are not available online.
Contact the Lobbyist Division here for assistance.
|
Search data is collected from registration records and disclosure reports
submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining
lobbying services to register annually, and submit disclosure reports twice a year.
|
| Your comments are welcome:
submit feedback
|
|
| Disclosure reporting details |
|
Back to search detail summary
|
|
:
01/01/2023 - 06/30/2023
|
|
Authorizing Officer name
|
John
F.X.
Heffernan
|
|
Title
|
Principal
|
|
Business name
|
Park Street Strategies, LLC
|
|
Address
|
121 Mount Vernon Street
|
|
City, state, zip code
|
Boston, MA 02108
|
|
Country
|
US
|
|
Phone
|
617-981-0015
|
|
|
|
|
Client Compensation
|
| Acadia Pharmaceuticals Inc. |
$30,000.00
|
| Biotechnology Innovation Organization (BIO) |
$27,000.00
|
| Horizon Therapeutics USA, Inc. |
$36,000.00
|
| Karuna Pharmaceuticals, Inc. |
$36,000.00
|
| Massachusetts Biotechnology Council, Inc. |
$60,000.00
|
| PTC Therapeutics, Inc. |
$30,000.00
|
| Sage Therapeutics, Inc. |
$33,000.00
|
| UCB, Inc. |
$22,500.00
|
| Total salaries received |
$274,500.00
|
|
|
| |
|
Compensation/Salaries Paid
|
|
John F.X. Heffernan
|
$91,000.00
|
| Total salaries paid |
$91,000.00
|
|
| |
|
Activities, Bill Numbers and Titles
|
| No activities, bill numbers or bill titles were disclosed for this reporting period. |
|
| |
|
Operating Expenses
|
| 01/31/2023 |
Ward & Lawless LLC, compliance support services
|
Other operating expenses
|
$900.00
|
| 03/22/2023 |
Staples
|
Photocopies, scans
|
$1.24
|
| 01/03/2023 |
Greater Boston Chamber
|
Professional dues
|
$350.00
|
| 06/30/2023 |
Meeting House Office & Retail
|
Internet fees
|
$300.00
|
| 03/01/2023 |
USPS
|
Postage, shipping, delivery
|
$4.77
|
| 06/30/2023 |
Meeting House Office & Retail
|
Rent
|
$6,570.90
|
| 06/30/2023 |
AT&T Wireless
|
Telephone, cell phone, handheld
|
$757.38
|
| 04/28/2023 |
Amity Insurance
|
Other operating expenses
|
$2,508.64
|
| | | Total operating expenses |
$11,392.93
|
|
| |
|
Meals, Travel, and Entertainment Expenses
|
| 01/05/2023 | Park Street Strategies, LLC |
Travel
|
ParkMobile meter
|
John Heffernan;Joseph Boncore;Kendalle Burlin O’Connell
|
$4.35
|
| 02/16/2023 | Park Street Strategies, LLC |
Travel
|
LAZ Parking
|
John Heffernan;Julie Garner;Denise Garlick, State Representative
|
$15.00
|
| 04/04/2023 | Park Street Strategies, LLC |
Travel
|
LAZ Parking
|
John Heffernan;David Goggin;Pat Cerundolo;Kendalle Burling O’Connell
|
$40.00
|
| 04/18/2023 | Park Street Strategies, LLC |
Travel
|
MCCA garage
|
John Heffernan;Pat Cerundolo
|
$18.00
|
| 05/04/2023 | Park Street Strategies, LLC |
Travel
|
LAZ Parking
|
John Heffernan;Daniel Amburn;Kaitlyn Sprague
|
$25.00
|
| 05/08/2023 | Park Street Strategies, LLC |
Travel
|
ParkMobile
|
John Heffernan;Pat Cerundolo;Kendall Burlin O’Connell
|
$4.35
|
| 05/08/2023 | Park Street Strategies, LLC |
Travel
|
MCCA garage
|
John Heffernan;Adrian Madaro, State Representative
|
$18.00
|
| 05/25/2023 | Park Street Strategies, LLC |
Travel
|
ParkMobile
|
John Heffernan;Pat Cerundolo;Nick Doherty
|
$8.70
|
| 05/25/2023 | Park Street Strategies, LLC |
Meal
|
Alcove
|
John Heffernan;Pat Cerundolo;Nick Doherty
|
$263.42
|
| 05/30/2023 | Park Street Strategies, LLC |
Travel
|
ParkMobile
|
John Heffernan;Kendalle Burlin O’Connell
|
$4.35
|
| | | | | Total amount |
$401.17
|
|
| |
|
Additional Expenses
|
| No additional expenses were filed for this disclosure reporting period. |
|
| |
|
Campaign Contributions
|
| No campaign contributions were filed for this disclosure reporting period. |
|
| |
|
Lobbyist: John F.X. Heffernan
|
|
Client:
Acadia Pharmaceuticals Inc.
|
|
|
|
Senate Bill
|
612
|
An Act relative to promoting healthcare access and affordability for patients
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1176
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: John F.X. Heffernan
|
|
Client:
Horizon Therapeutics USA, Inc.
|
|
|
|
House Bill
|
953
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
978
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1176
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: John F.X. Heffernan
|
|
Client:
Karuna Pharmaceuticals, Inc.
|
|
|
|
House Bill
|
984
|
An Act relative to access to care for serious mental illness
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1176
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
989
|
An Act for supportive care for serious mental illness
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
610
|
An Act for supportive care for serious mental illness
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
631
|
An Act relative to access to care for serious mental illness
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: John F.X. Heffernan
|
|
Client:
PTC Therapeutics, Inc.
|
|
|
|
House Bill
|
1176
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
612
|
An Act relative to promoting healthcare access and affordability for patients
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: John F.X. Heffernan
|
|
Client:
Sage Therapeutics, Inc.
|
|
|
|
House Bill
|
1176
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
989
|
An Act for supportive care for serious mental illness
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
2164
|
An Act relative to patient assessment and notification prior to prescribing certain medications
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
631
|
An Act relative to access to care for serious mental illness
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
610
|
An Act for supportive care for serious mental illness
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
984
|
An Act relative to access to care for serious mental illness
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: John F.X. Heffernan
|
|
House Bill
|
1176
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
953
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
2197
|
An Act to protect Massachusetts public health from PFAS
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
978
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
612
|
An Act relative to promoting healthcare access and affordability for patients
|
Neutral
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: John F.X. Heffernan
|
|
Client:
Massachusetts Biotechnology Council, Inc.
|
|
|
|
House Bill
|
945
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1215
|
An Act relative to pharmacy benefit managers
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
630
|
An Act ensuring access to specialty medications
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1369
|
An Act to establish a pilot program for specialty pharmacy in urology
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
978
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1239
|
An Act establishing Medicare for all in Massachusetts
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
689
|
An Act relative to patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1418
|
An Act to restore integrity in the marketing of pharmaceutical products and medical devices
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1016
|
An Act to enact pharmacy benefit manager duties
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1247
|
An Act relative to pharmacy benefit managers reimbursements to pharmacies in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
704
|
An Act prohibiting discrimination against 340b drug discount program participants
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1425
|
An Act relative to pharmacists as healthcare providers
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
953
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1219
|
An Act enhancing the market review process
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
656
|
An Act to reduce the cost of pharmacy benefits
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1375
|
An Act relative to postpartum depression screening
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1055
|
An Act relative to pharmaceutical gag clauses
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1250
|
An Act to advance health equity
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
714
|
An Act relative to pharmaceutical gag clauses
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1862
|
An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
445
|
An Act to expand access to computer science coursework
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1147
|
An Act ensuring access to specialty medications
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
3587
|
An Act to ensure access to prescription medications
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
749
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
564
|
An Act incentivizing the awarding of industry-recognized credentials
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1150
|
An Act to ensure access to generic medication
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
3770
|
An Act to improve the Commonwealth's competitiveness, affordability, and equity
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
750
|
An Act relative to primary care for you
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1056
|
An Act establishing a commission to study maximum allowable costs lists
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
2163
|
An Act relative to postpartum depression screenings
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
715
|
An Act to ensure access to prescription medications
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2397
|
An Act to improve the Commonwealth's competitiveness, affordability, and equity
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
444
|
An Act to expand the use of career and academic plans
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1131
|
An Act relating to patient cost, benefit and coverage information, choice, and price transparency
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
3009
|
An Act creating a workforce skills cabinet supporting pathways to success
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
744
|
An Act establishing medicare for all in Massachusetts
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
944
|
An Act reining in premiums through stronger rate review
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1208
|
An Act establishing a state-wide drug repository program
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
616
|
An Act relating to patient cost, benefit and coverage information, choice, and price transparency
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1191
|
An Act relative to pay range disclosure
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
593
|
An Act for trauma informed and social and emotional learning supports and training expansion act
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1197
|
An Act to provide rapid whole genome sequencing
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
256
|
An Act to create and expand student pathways to success
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
783
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
850
|
An Act concerning the use of animals in product testing
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1201
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
277
|
An Act to expand access to computer science coursework
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
799
|
An Act to advance health equity
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1
|
An Act making appropriations for the Fiscal Year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1074
|
An Act relative to cancer patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
2249
|
An Act relative to the availability of prescription medication during an emergency
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
732
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
934
|
An Act to enact the pharmacy benefit manager compensation reform
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1205
|
An Act relative to prescription drug price transparency
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
609
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
801
|
An Act strengthening health spending accountability processes within the health policy commission and the center for health information and analysis
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
943
|
An Act to reduce co-pays for people with chronic conditions
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1206
|
An Act establishing a commission to review contracts between pharmaceutical benefit managers and MassHealth
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
612
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1181
|
An Act relative to transparency in the workplace
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
592
|
An Act to create and expand student pathways to success
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1176
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
3
|
An Act making appropriations for the fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
767
|
An Act to define modest meals and refreshments in prescriber education settings
|
Oppose
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
Lobbyist: John F.X. Heffernan
|
|
Client:
Biotechnology Innovation Organization (BIO)
|
|
|
|
House Bill
|
945
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1215
|
An Act relative to pharmacy benefit managers
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
630
|
An Act ensuring access to specialty medications
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1369
|
An Act to establish a pilot program for specialty pharmacy in urology
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
978
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1239
|
An Act establishing Medicare for all in Massachusetts
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
689
|
An Act relative to patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1418
|
An Act to restore integrity in the marketing of pharmaceutical products and medical devices
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
1016
|
An Act to enact pharmacy benefit manager duties
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1247
|
An Act relative to pharmacy benefit managers reimbursements to pharmacies in the Commonwealth
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
704
|
An Act prohibiting discrimination against 340b drug discount program participants
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1425
|
An Act relative to pharmacists as healthcare providers
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
953
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1219
|
An Act enhancing the market review process
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
656
|
An Act to reduce the cost of pharmacy benefits
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1375
|
An Act relative to postpartum depression screening
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1055
|
An Act relative to pharmaceutical gag clauses
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1250
|
An Act to advance health equity
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
714
|
An Act relative to pharmaceutical gag clauses
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1862
|
An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
445
|
An Act to expand access to computer science coursework
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1147
|
An Act ensuring access to specialty medications
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
3587
|
An Act to ensure access to prescription medications
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
749
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
564
|
An Act incentivizing the awarding of industry-recognized credentials
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1150
|
An Act to ensure access to generic medication
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
3770
|
An Act to improve the Commonwealth's competitiveness, affordability, and equity
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
750
|
An Act relative to primary care for you
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1056
|
An Act establishing a commission to study maximum allowable costs lists
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
2163
|
An Act relative to postpartum depression screenings
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
715
|
An Act to ensure access to prescription medications
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
2397
|
An Act to improve the Commonwealth's competitiveness, affordability, and equity
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
444
|
An Act to expand the use of career and academic plans
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1131
|
An Act relating to patient cost, benefit and coverage information, choice, and price transparency
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
3009
|
An Act creating a workforce skills cabinet supporting pathways to success
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
744
|
An Act establishing medicare for all in Massachusetts
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
944
|
An Act reining in premiums through stronger rate review
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1208
|
An Act establishing a state-wide drug repository program
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
616
|
An Act relating to patient cost, benefit and coverage information, choice, and price transparency
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
1191
|
An Act relative to pay range disclosure
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
593
|
An Act for trauma informed and social and emotional learning supports and training expansion act
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1197
|
An Act to provide rapid whole genome sequencing
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
256
|
An Act to create and expand student pathways to success
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
783
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
850
|
An Act concerning the use of animals in product testing
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1201
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
277
|
An Act to expand access to computer science coursework
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
799
|
An Act to advance health equity
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1
|
An Act making appropriations for the Fiscal Year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1074
|
An Act relative to cancer patient access to biomarker testing to provide appropriate therapy
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
2249
|
An Act relative to the availability of prescription medication during an emergency
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
732
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
934
|
An Act to enact the pharmacy benefit manager compensation reform
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1205
|
An Act relative to prescription drug price transparency
|
Oppose
|
$0.00
|
N/A
|
|
Senate Bill
|
609
|
An Act relative to consumer deductibles
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
801
|
An Act strengthening health spending accountability processes within the health policy commission and the center for health information and analysis
|
Oppose
|
$0.00
|
N/A
|
|
House Bill
|
943
|
An Act to reduce co-pays for people with chronic conditions
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
1206
|
An Act establishing a commission to review contracts between pharmaceutical benefit managers and MassHealth
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
612
|
An Act relative to promoting healthcare access and affordability for patients
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
1181
|
An Act relative to transparency in the workplace
|
Neutral
|
$0.00
|
N/A
|
|
House Bill
|
592
|
An Act to create and expand student pathways to success
|
Support
|
$0.00
|
N/A
|
|
House Bill
|
1176
|
An Act relative to promoting comprehensive transparency in the pharmaceutical industry
|
Support
|
$0.00
|
N/A
|
|
Senate Bill
|
3
|
An Act making appropriations for the fiscal year 2024 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$0.00
|
N/A
|
|
Senate Bill
|
767
|
An Act to define modest meals and refreshments in prescriber education settings
|
Oppose
|
$0.00
|
N/A
|
| | | |
Total amount
|
$0.00
| |
|
|
|
|
Meals, Travel, and Entertainment Expenses
|
| No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
| |
|
Additional Expenses
|
| No additional expenses were filed for this disclosure reporting period. |
|
| |
|
Campaign Contributions
|
| 01/23/2023 | John F.X. Heffernan |
Committee for a Democratic Senate PAC
|
Committee for a Democratic Senate PAC
|
$200.00
|
| 01/25/2023 | John F.X. Heffernan |
Ronald Mariano
|
State Representative, 3rd Norfolk
|
$200.00
|
| 02/21/2023 | John F.X. Heffernan |
Aaron Michlewitz
|
State Representative, 3rd Suffolk
|
$200.00
|
| 03/06/2023 | John F.X. Heffernan |
Bill MacGregor
|
State Representative, 10th Suffolk
|
$200.00
|
| 03/07/2023 | John F.X. Heffernan |
Tom Stanley
|
State Representative, 9th Middlesex
|
$200.00
|
| 03/24/2023 | John F.X. Heffernan |
Sal DiDomenico
|
State Senator, Middlesex and Suffolk
|
$200.00
|
| 03/29/2023 | John F.X. Heffernan |
Kate Hogan
|
State Representative, 3rd Middlesex
|
$200.00
|
| 03/30/2023 | John F.X. Heffernan |
Richard Haggerty
|
State Representative, 30th Middlesex
|
$200.00
|
| 04/03/2023 | John F.X. Heffernan |
Danielle Gregoire
|
State Represenative, 4th Middlesex
|
$200.00
|
| 04/06/2023 | John F.X. Heffernan |
Dan Cahill
|
State Representative, 10th Essex
|
$200.00
|
| 04/10/2023 | John F.X. Heffernan |
Michael J. Rodriguesv
|
State Senator, 1st Bristol and Plymouth
|
$200.00
|
| 04/11/2023 | John F.X. Heffernan |
Jerry Parisella
|
State Representative, 6th Essex
|
$200.00
|
| 04/11/2023 | John F.X. Heffernan |
Carole Fiola
|
State Representative, 6th Bristol
|
$200.00
|
| 04/11/2023 | John F.X. Heffernan |
John Mahoney
|
State Representative, 13th Worcester
|
$200.00
|
| 04/12/2023 | John F.X. Heffernan |
David Biele
|
State Representative, 4th Suffolk
|
$200.00
|
| 04/13/2023 | John F.X. Heffernan |
Meghan Kilcoyne
|
State Representative, 12th Worcester
|
$200.00
|
| 04/13/2023 | John F.X. Heffernan |
Ann-Margaret Ferrante
|
State Representative, 5th Essex
|
$200.00
|
| 04/25/2023 | John F.X. Heffernan |
Brendan Crighton
|
State Senator, 3rd Essex
|
$200.00
|
| 04/25/2023 | John F.X. Heffernan |
Josh Cutler
|
State Representative, 6th Plymouth
|
$200.00
|
| 04/26/2023 | John F.X. Heffernan |
Jeffrey Roy
|
State Representative, 10th Norfolk
|
$100.00
|
| 04/26/2023 | John F.X. Heffernan |
Marjorie Decker
|
State Representative, 25th Middlesex
|
$100.00
|
| 05/08/2023 | John F.X. Heffernan |
Adrian Madaro
|
State Representative, 1st Suffolk
|
$200.00
|
| 05/17/2023 | John F.X. Heffernan |
Nick Collins
|
State Senator, 1st Suffolk
|
$200.00
|
| 05/17/2023 | John F.X. Heffernan |
Christopher Worrell
|
State Representative, 5th Suffolk
|
$200.00
|
| 05/24/2023 | John F.X. Heffernan |
Jack Lewis
|
State Representative, 7th Middlesex
|
$200.00
|
| 05/24/2023 | John F.X. Heffernan |
Bill Driscoll Jr.
|
State Representative, 7th Norfolk
|
$200.00
|
| 06/20/2023 | John F.X. Heffernan |
Daniel J. Ryan
|
State Representative, 2nd Suffolk
|
$200.00
|
| 06/20/2023 | John F.X. Heffernan |
Lydia Edwards
|
State Senator, 3rd Suffolk
|
$200.00
|
| 06/21/2023 | John F.X. Heffernan |
Dan Hunt
|
State Representative, 13th Suffolk
|
$200.00
|
| | | | Total contributions |
$5,600.00
|
|
|
|
|
|